Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Stock
-
Total 13F shares
-
7,983,447
-
Share change
-
-1,203,762
-
Total reported value
-
$4,230,000
-
Price per share
-
$0.53
-
Number of holders
-
35
-
Value change
-
-$1,250,214
-
Number of buys
-
12
-
Number of sells
-
13
Institutional Holders of Ginkgo Bioworks Holdings, Inc. - Stock (DNABW) as of Q2 2022
As of 30 Jun 2022,
Ginkgo Bioworks Holdings, Inc. - Stock (DNABW) was held by
35 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,983,447 shares.
The largest 10 holders included
CVI Holdings, LLC, Ionic Capital Management LLC, Weiss Asset Management LP, MORGAN STANLEY, DARLINGTON PARTNERS CAPITAL MANAGEMENT, LP, Clearbridge Investments, LLC, Murchinson Ltd., Johnson Financial Group, LLC, Woodline Partners LP, and Taconic Capital Advisors LP.
This page lists
35
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.